National HealthCare Corporation (NHC)
NYSEAMERICAN: NHC · Real-Time Price · USD
226.03
-2.94 (-1.28%)
Jul 31, 2026, 4:00 PM EDT - Market closed
National HealthCare Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 3,531 | 2,130 | 1,662 | 1,419 | 914 | 1,050 | |
Market Cap Growth | 138.76% | 28.17% | 17.14% | 55.26% | -12.96% | 2.85% |
Enterprise Value | 3,311 | 1,967 | 1,663 | 1,290 | 860.37 | 965.9 |
Last Close Price | 226.03 | 137.09 | 107.56 | 92.42 | 59.50 | 67.94 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 28.71 | 17.87 | 16.47 | 21.29 | 41.03 | 7.56 |
Forward PE | - | 17.52 | 17.52 | 17.52 | 17.52 | 17.52 |
PS Ratio | 2.31 | 1.40 | 1.27 | 1.24 | 0.84 | 0.98 |
PB Ratio | 3.23 | 1.99 | 1.70 | 1.56 | 1.05 | 1.16 |
P/TBV Ratio | 3.94 | 2.44 | 2.12 | 1.94 | 1.32 | 1.44 |
P/FCF Ratio | 20.96 | 14.33 | 20.85 | 17.03 | - | 45.65 |
P/OCF Ratio | 16.94 | 11.51 | 15.49 | 12.76 | 104.53 | 16.83 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 2.17 | 1.30 | 1.27 | 1.13 | 0.79 | 0.90 |
EV/EBITDA Ratio | 18.88 | 11.35 | 12.61 | 12.97 | 13.14 | 10.45 |
EV/EBIT Ratio | 25.50 | 15.32 | 18.50 | 22.45 | 34.41 | 18.66 |
EV/FCF Ratio | 19.66 | 13.23 | 20.87 | 15.49 | - | 42.00 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.01 | 0.04 | 0.18 | 0.07 | 0.10 | 0.15 |
Debt / EBITDA Ratio | 0.22 | 0.50 | 1.63 | 0.94 | 1.92 | 1.80 |
Debt / FCF Ratio | 0.23 | 0.59 | 2.70 | 1.12 | - | 7.25 |
Net Debt / Equity Ratio | -0.20 | -0.16 | 0.00 | -0.14 | -0.06 | -0.10 |
Net Debt / EBITDA Ratio | -1.25 | -0.97 | -0.01 | -1.31 | -0.86 | -0.97 |
Net Debt / FCF Ratio | -1.30 | -1.13 | -0.02 | -1.56 | 2.64 | -3.89 |
Asset Turnover | 1.00 | 0.99 | 0.92 | 0.88 | 0.81 | 0.78 |
Quick Ratio | 1.58 | 1.56 | 1.50 | 1.55 | 1.43 | 1.34 |
Current Ratio | 1.86 | 1.82 | 1.81 | 1.89 | 1.79 | 1.62 |
Return on Equity (ROE) | 11.65% | 11.92% | 10.78% | 7.30% | 2.24% | 16.30% |
Return on Assets (ROA) | 6.58% | 6.35% | 4.75% | 3.27% | 1.37% | 3.47% |
Return on Invested Capital (ROIC) | 11.26% | 10.27% | 7.64% | 5.28% | 2.24% | 6.45% |
Return on Capital Employed (ROCE) | 10.20% | 10.02% | 7.54% | 5.29% | 2.25% | 4.66% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 3.50% | 5.59% | 6.07% | 4.70% | 2.44% | 13.23% |
FCF Yield | 4.77% | 6.98% | 4.80% | 5.87% | - | 2.19% |
Dividend Yield | 1.19% | 1.82% | 2.23% | 2.51% | 3.77% | 3.07% |
Payout Ratio | 34.04% | 32.25% | 36.27% | 53.24% | 154.17% | 23.11% |
Buyback Yield / Dilution | -0.51% | -0.31% | -1.44% | 0.45% | -0.20% | -0.31% |
Total Shareholder Return | 0.68% | 1.52% | 0.79% | 2.97% | 3.58% | 2.76% |